| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.35B | -0.9% |
| Gross profit | ¥0.07B | — |
| Operating income | ¥0.02B | — |
| Net income | ¥0.02B | -49.2% |
| Gross margin | 19.2% | Net margin 5.2% |
| Revenue Q/Q | +3.4% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.29B | 80.8% |
| R&D | ¥0.02B | 6.2% |
| SG&A | ¥0.01B | 3.8% |
| Tax & other | ¥0.00B | 0.7% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
万孚生物 ・ 首华燃气 ・ 蓝海华腾 ・ 赛升药业 ・ 东杰智能 ・ 蓝晓科技 ・ 恒锋工具 ・ 光智科技 ・ 华自科技 ・ 通合科技 ・ 华图山鼎 ・ 润欣科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies